Zynerba Pharmaceuticals, Inc. ZYNE
1.30 +1.30
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 | FY 2018 Dec 31, 2018 |
|---|---|---|---|---|---|
| 35.25M | 36.77M | 52.06M | 34.32M | 40.48M | |
| 21.10M | 21.42M | 35.65M | 20.38M | 27.25M | |
| 14.15M | 15.35M | 16.41M | 13.94M | 13.24M | |
| -35.25M | -36.77M | -52.06M | -34.32M | -40.40M | |
| -35.04M | -37.31M | -51.34M | -32.94M | -39.91M | |
| -35.04M | -37.31M | -51.34M | -32.94M | -39.91M | |
| -35.04M | -37.31M | -51.34M | -32.94M | -39.91M | |
| -35.04M | -37.31M | -51.34M | -32.94M | -39.91M | |
| -0.82 | -0.95 | -1.90 | -1.50 | -2.61 | |
| -0.82 | -0.95 | -1.90 | -1.50 | -2.61 | |
| -0.82 | -0.95 | -1.90 | -1.50 | -2.61 | |
| -35.04M | -37.31M | -51.34M | -32.94M | -39.91M | |
| -35.04M | -37.31M | -51.34M | -32.94M | -39.91M | |
| 42.66M | 39.26M | 27.02M | 22.00M | 15.31M | |
| 42.66M | 39.26M | 27.02M | 22.00M | 15.31M |